Quick Answer
Vir Biotechnology, Inc. reported Stockholders Equity of $765.28 million for fiscal year 2025.
Vir Biotechnology, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $765.28M | -33.5% |
| 2024 | $1.15B | -27.7% |
| 2023 | $1.59B | -23.5% |
| 2022 | $2.08B | +45.1% |
| 2021 | $1.43B | +99.7% |
| 2020 | $716.85M | +69.1% |
| 2019 | $423.94M | +336.6% |
| 2018 | -$179.18M | -160.0% |
| 2017 | -$68.92M | -764.5% |
| 2016 | -$7.97M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $796.10M | -35.8% | -16.0% |
| June 30, 2025 | $947.47M | -33.9% | -9.2% |
| March 31, 2025 | $1.04B | -32.5% | -9.3% |
| December 31, 2024 | $1.15B | -27.7% | -7.3% |
| September 30, 2024 | $1.24B | -25.9% | -13.5% |
| June 30, 2024 | $1.43B | -20.8% | -7.3% |
| March 31, 2024 | $1.55B | -21.5% | -2.7% |
| December 31, 2023 | $1.59B | -23.5% | -5.1% |
- Vir Biotechnology, Inc. showed a decrease of -33.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, Vir Biotechnology, Inc.’s stockholders equity has grown by 9699.5% (from -$7.97 million to $765.28 million).
- The most recent figure is from Vir Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: